Preoperative Co‐Mutation of BRAFV600E and TERT Promoter Predicts Tumor Aggressiveness and Recurrence‐Free Survival in Papillary Thyroid Carcinoma. - Deng, Chang; Cao, Yijia; Deng, Yuping; Chun, Lin; Xinliang, Su (Cancer Medicine, 2026)